Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor.

ABSTRACT:

SUBMITTER: Magone MT 

PROVIDER: S-EPMC12079666 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature